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restanosls rnle (-50% DS) was 5636. 9 pts (33%) hod a terget IOSlOn revas- 
culnrlenllon. 
Conc/~r$ion~ RA wllh aatuncllvo LPBD pmvldas anto and oHocllve roduc- 
lion ol ntenollc tissue In dllluao IR wllh oxcellont ncuto anglornphlc rosutla. 
Howevnr, the anglographlc rnto ol recurrent restanoals In these pntlenls 
rematns high. 
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Ratatlonnl AthOreCtOmy for Stsnt~Rertsnosla 
Rwultr In Lasr Ilanslent Pwtuelon Raductlon 
E;m~ard to Natlvs Non~atantad Coronary 
J. vam Caht, K.-C. Koch, E, Klelnhana, HG, Ktuan, S, Nlnnamnrin, 
G. Schulz, Udalrish !&o/l, Peter &math. Un&onr~fy HospfiaI, RWRI 
Aaohan, Garmafly 
Elackproitnd: Ratatlannl nlhamclomy (Rh) tmquantty mautla In lmnatsnt hy 
popsrhialon dua to parlpharal ahalrucllon by mlnmanvltotlan, athommntoua 
dabrls, release al vnno~cllva substnnoae. platotet aggregation, or vossot 
spasm. Thlr study campsms lho lnoldoncn and aavorlty at myooankal per- 
fuslan delacts Induced by RA In naliva camnary attorlos with dotacta during 
RA tar wtantmnlanaala. 
h4efhofW 25 p1r1 undatgotng RA tar rastenoaod atoms (gmup A) worn 
studled by aertal To99m~saatsmlbt aclnllpraphy (SPECT) at mst balom AA 
(pmAA), durtng AA (lmcar tntecllon In the cath Inb Immadlotaly nlter mlnaval 
al the last burr In tho guiding osthetor: SPECT nknr GO mln). and 2 days ntlor 
AA (paaN?A). Tho mauh worn compared with 25 pla (group S). motchod tar 
Age, g@nd@r, IeslOn loootlzntton and chamclarlellca, with RA In non.elontod 
type B and C cornnary laalona. The RA tachnlqua (cancomllant modtca- 
tlon, stepped burr nppmach. short burr runs, burr/artaly ratio -0.7. post RA 
dltatalton) dld nal dlhar botwoon both groups. Far mglannl Tc-99m uptaho 
analysta. myooardlnl poduslon was axprossod as ?b al tha Rg wllh mnxlmnl 
tracer Uplake. Tho extent ol hypoper’tuslon during RA was assesaoct as num- 
bar ot Rglpl wlth uptake .2SD al narmal. nnd tho sovonty was oxpmssod as 
uptake during RA compnmd la pmRA and postRA: 
p 0 on1 \!?I prnR clr1d “S postR 
Conclusions: Tha extant nnd soverily 01 RA mlalod transient hypopertu- 
slon In mstonosod slants is compnrablo lo non-alanlod vosaals dospllo Iho 
nn9lo9raphlc ovldonco 01 less “slow llaw”. Thus. the type 01 abraded tissue 
may bo less lmpodnnl compamd IO other factors such as platelet activation. 
1061-60 DIrectIonal Atherectomy tar Treatment of Stent 
Restenosls - Feaslbillty and Hlstopathologlcal 
Findings In 28 Patients 
N. Caltelaens. U. Gerchens. R. Mueller. J. Gorlach. E. Grubs. Siegbug 
Uosptfal. Sregburg. Gemleny 
Debulkctg techniques domonslrated promising results the treatment 01 stenl 
restenosis interventions campamd with PTCA. Directional atherectomy @CA) 
1s suitable to extracl a large ammount 01 tissue. 
Methods: We portormod DCA in 30 pts. with stem mstenosis in 5 dIRerent 
stem-types using a 7 Fr. DCA-device (minimal diameter: 3.0 mm). Extracted 
lissue was examined hislopalhologxzally including staining lor alpha-achn and 
vimotin to IdenNy smooth muscle cells (SMC). siderin to delecl slent material 
and Ki 67 to estimate the prolileralion~lndex. lntervenlion was completed 
routinely by ballon dilatation and IVUS followed by Ott-line QCA. Follow-up 
mcluclod 46 hours and a phone call atler 4 weeks, 
Resub: In 26 pts. extensive debulking was successlully performed exer- 
cising 12 f 4 cuts. In 23 pts (82%) “stand-alone”- DCA provided a decent 
result (<2u% residual stenosis). In 2 pts. the device could not be advanced 
to an angulatod lesion dospito preditatation. We recorded no serious com- 
plications (dealh. Mt. CARG). In 3 pts final PTCA was not possible because 
of balloon rupture. In 19 pts (68%) stem material in :he extracted specimen 
could be detected macroscopically. Siderin-staining was positive in 25 pts. 
(89%). 
Histopalhological findings demonstrated positive alpha-actin and vimetin 
staining documenting SMC with a high proliteration-index 
Conclusion: DCA Is a save and fenslble method for lntotventlonat treet- 
monl of slant rostenosls. Allhough stem material can usually be detected 
In the speclmcn, this does not attect the successful procedumt outcome. 
Extracted tissue conlalns SMC with hlgh pmtlfarallon Index 
I1061 -61 1 Randomized Trial of ROtntlonal Athemctomy VI 
Balloon Angloplasty for InWEnt Won&mods 
(ROSTER) 
SK. Sharma, A. Ktnl, S. Duwurt, Pi D%nting, I. Coxano, Cl Dnngss. 
Ft. Vldhun, T King, l’, Cacks, J. Mnnnur. hfi. Skifti Hmpllal. N1: LISA 
In-stont restonaais (ISR) preaanla e dlfftoult challenge due to high mpest 
rastanosl~ rnlns (up to 76?h) nltar batlOOn ongtoplaaty (ITCAl. Rwml an 
aur prellmtnary expertsnsa with mtsttonat othorestomy (RA) tar WI. a rsn- 
damlrad lrtal compodng RA (lollowod by R baktin dilatstlon uplo 4-g atm) 
versus high pmssure (1~10 mm) PTCA wss etsrled m llAh3. A lalsl of S2 
palianla with ISR (dalined as +l?6 diam. obst. +I weeks post stenting) 
wnm randomtrod (26 RA. Pit PICA), 
Reaub: Rsaatine clinast and snglagmphia vanablos ware not ditiemnt m 
the two graup. Tha time mtorvsl at tSR tram inilial stenting was 159 2 02 
dsys snd maen tosion length al 19.8 i. 4.7 mm. In lhe RA group. mean burr 
RIPBI WRB 2.15 mm, mean burr numbers 2.2, mean burr-ro+nIsry rsko at 0.7 
and moan post ditatatian batlwn pressure 4.4 aim. In tha PTCA group, mean 
bntlaan SIZO was 3.4 mm (0.2 mm greater than lhe initial slcnt deptaymenl) 
and maan inllation prossum 12 atm. IVUS data: RA gwup?4% 01 the lumrnat 
gain waa duo ta plaque debulking by RA. 26% dus to plaque compressfan by 
aubaoquont balloon dllalatian, nnd stont expansion contributed none; PICA 
group 62% at the tumtnat gain was due to plaque compression and 39% 
due to ludher slant axpanslon, There were no prooedural compkitii and 
CKMS reloaae was 16% in the RA gmup and 129b in tha PTCA group (p = 
NS). At the mean lollaw-up al 5 f 3 months. lhoro have baen no C-wave Ml 
or denth; ane pahanl in the PTCAgmup underwent CABG. Climcat restenosrs 
was dolinod as angiographtc mstenos1s. target vessel revasculanrahon or 
mcurmnt anglna Class Ill-IV, 
VSlTlflblOS RAltl=20) PTCA ,n = 26) P 
Aol Va~scl01~m (mm) 31+04 32 t 04 NS 
ML0 Pro (mm) aa f 04 09104 NS 
MLD Posl (mm) 26104 25 i 04 aoj 
olsaoclIonislonl us0 [““I 2 tat 13 (50) -001 
ClKltcal Ros1onosls I%\ I 141 7 1271 a03 
Corrc/usrons: In Ihe ROSTER trial for in-stenl restenofis. rolahonal ather- 
ectomy resullod in better anglograph% lummal gain. lower mcidence 01 drs- 
sechon and stem use. and tower cknical restenosis compared mth PTCA 
Thus mtauonal alhorectomy should be prelerred over PTCA tar Intenentronal 
lroatmonl ol cn-stem restenasc. 
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Although drliuse in-stent restenosis (length * 10 mm) IS associated with a 
htgh late ckmcal recurrence after repeal angloplasty. the precise contribution 
of restenosls length lo late outcome is not known. To address lhw issue. we 
revlewed the late outcome of 157 pahents (163 lesions) treated tar m-stem 
restenosts in a multicenter registry usmg either PTCA (n = 65) or Exlmer 
laser an9loptasty (n = 92). Lessons were grouped accordmg to leston length 
(table). Baseline clintcal characteristics were similar. 
Rdl~rence (mm) 
Prc ML0 (mm) 
Pre O.DS 
Fmal ML0 (mm) 
Final “.LS 
Any TLR 
Rn~enl PTCA 
= P (ANOVA) 0.05: TLR = tar@ lesson revascular~zal~on 
We conclude that patients with in-stent restenosis of the longer lesion 
have a higher rate of repeat PTCA for second restenosis after percuta- 
neous therapy. Diffuse (>20 mm) restenosis may warrant more aggressive 
debulking or adjunctive therapy (pharmacology or radiation). 
